한글목차

맹장염 진단 및 치료의 동향과 전망

세계 맹장염 진단 및 치료 시장은 2024년부터 2030년까지 7.1%의 연평균 복합 성장률(CAGR)로 성장을 지속하여 2030년까지 약 140억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 맹장염 및 소아 맹장염의 유병률 증가, 맹장염에 대한 인식 증가, 세계 의료비 지출 증가입니다. 세계 맹장염 진단 및 치료 시장의 미래는 병원, 진료소 및 영상 진단센터 시장에서의 비즈니스 기회로 인해 유망합니다.

맹장염 진단 및 치료 시장 인사이트

급성 맹장염은 몇 시간에서 며칠 사이에 빠르게 발생하는 맹장의 염증을 특징으로 하기 때문에 예측 기간 동안 높은 성장세를 보일 것으로 루킨텔은 예상하고 있습니다.

이 시장에서 병원 및 진료소가 가장 큰 시장으로 남을 것으로 보입니다.

북미는 맹장염의 높은 유병률과 사람들의 맹장염에 대한 인식이 높아짐에 따라 예측 기간 동안 가장 규모가 큰 지역으로 남을 것으로 보입니다.

이 보고서는 다음과 같은 11가지 주요 질문에 대한 답변을 제시합니다.

• Q.1. 시장 부문 중 가장 유망하고 성장성이 높은 기회는 무엇인가?
• Q.2. 향후 성장이 가속화될 부문과 그 이유는?
• Q.3. 향후 성장이 가속화될 것으로 예상되는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은? 시장의 주요 과제와 비즈니스 리스크는 무엇인가?
• Q.5. 이 시장에서의 비즈니스 리스크와 경쟁 위협은 무엇인가?
• Q.6. 이 시장의 새로운 트렌드와 그 이유는?
• Q.7. 시장에서의 고객 수요 변화에는 어떤 것들이 있는가?
• Q.8. 이 시장의 새로운 발전과 그 발전을 주도하고 있는 기업은?
• Q.9. 이 시장의 주요 기업은? 주요 기업들은 사업 성장을 위해 어떤 전략적 노력을 기울이고 있는가?
• Q.10. 이 시장의 경쟁 제품에는 어떤 것들이 있으며, 소재 및 제품 대체에 따른 시장 점유율 하락의 위협은 어느 정도인가?
• Q.11. 지난 5년간 어떤 M&A가 이루어졌고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 맹장염 진단 및 치료 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향 및 예측 분석(2018-2030년)

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 맹장염 진단 및 치료 시장 동향(2018-2023) 및 예측(2024-2030)
• 유형별 세계의 맹장염 진단 및 치료 시장
  • 급성
  • 만성
• 진단 치료별 세계의 맹장염 진단 및 치료 시장
  • 진단
  • 치료
• 최종 용도별 세계의 맹장염 진단 및 치료 시장
  • 병원
  • 클리닉
  • 영상 진단센터

제4장 지역별 시장 동향 및 예측 분석(2018-2030년)

• 지역별 세계의 맹장염 진단 및 치료 시장
• 북미의 맹장염 진단 및 치료 시장
• 유럽의 맹장염 진단 및 치료 시장
• 아시아태평양의 맹장염 진단 및 치료 시장
• 기타 지역의 맹장염 진단 및 치료 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 유형별 세계의 맹장염 진단 및 치료 시장 성장 기회
  • 진단 치료별 세계의 맹장염 진단 및 치료 시장 성장 기회
  • 최종 용도별 세계의 맹장염 진단 및 치료 시장 성장 기회
  • 지역별 세계의 맹장염 진단 및 치료 시장 성장 기회
• 세계 맹장염 진단 및 치료 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 맹장염 진단 및 치료 시장 능력 확대
  • 세계의 맹장염 진단 및 치료 시장의 인수합병(M&A) 및 합작투자(JV)
  • 인증 및 라이선싱

제7장 유력 기업의 기업 개요

• Johnshon & Johnshon
• Pfizer
• Lupin
• Siemens
• Medtronic
• Cook
• Teva Pharmaceutical industries

영문목차

Appendicitis Diagnostics and Treatment Trends and Forecast

The future of the global appendicitis diagnostics and treatment market looks promising with opportunities in the hospital, clinic, and diagnostic imaging center markets. The global appendicitis diagnostics and treatment market is expected to reach an estimated $14 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of appendicitis and pediatric appendicitis, growing awareness towards appendicitis, and rising healthcare spending across the globe.

A more than 150-page report is developed to help in your business decisions.

Appendicitis Diagnostics and Treatment by Segment

The study includes a forecast for the global appendicitis diagnostics and treatment by type, diagnosis treatment, end use, and region.

Appendicitis Diagnostics and Treatment Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Acute
• Chronic

Appendicitis Diagnostics and Treatment Market by Diagnosis Treatment [Shipment Analysis by Value from 2018 to 2030]:

• Diagnosis
• Treatment

Appendicitis Diagnostics and Treatment Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Clinics
• Diagnostic Imaging Centers

Appendicitis Diagnostics and Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Appendicitis Diagnostics and Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies appendicitis diagnostics and treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the appendicitis diagnostics and treatment companies profiled in this report include-

• Johnshon & Johnshon
• Pfizer
• Lupin
• Siemens
• Medtronic
• Cook
• Teva Pharmaceutical Industries

Appendicitis Diagnostics and Treatment Market Insights

Lucintel forecasts that acute appendicitis is expected to witness higher growth over the forecast period as it is characterized by inflammation of the appendix that develops rapidly, over a period of hours or days.

Within this market, hospitals & clinics will remain the largest segment.

North America will remain the largest region over the forecast period due to high prevalence of appendicitis and increasing awareness of the disease among people.

Features of the Global Appendicitis Diagnostics and Treatment Market

Market Size Estimates: Appendicitis diagnostics and treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Appendicitis diagnostics and treatment market size by type, diagnosis treatment, end use, and region in terms of value ($B).

Regional Analysis: Appendicitis diagnostics and treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, diagnosis treatments, end uses, and regions for the appendicitis diagnostics and treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the appendicitis diagnostics and treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the appendicitis diagnostics and treatment market size?

Answer: The global appendicitis diagnostics and treatment market is expected to reach an estimated $14 billion by 2030.

Q.2 What is the growth forecast for appendicitis diagnostics and treatment market?

Answer: The global appendicitis diagnostics and treatment market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the appendicitis diagnostics and treatment market?

Answer: The major drivers for this market are increasing prevalence of appendicitis and pediatric appendicitis, growing awareness towards appendicitis, and rising healthcare spending across the globe.

Q4. What are the major segments for appendicitis diagnostics and treatment market?

Answer: The future of the appendicitis diagnostics and treatment market looks promising with opportunities in the hospital, clinic, and diagnostic imaging center markets.

Q5. Who are the key appendicitis diagnostics and treatment market companies?

Answer: Some of the key appendicitis diagnostics and treatment companies are as follows:

• Johnshon & Johnshon
• Pfizer
• Lupin
• Siemens
• Medtronic
• Cook
• Teva Pharmaceutical Industries

Q6. Which appendicitis diagnostics and treatment market segment will be the largest in future?

Answer: Lucintel forecasts that acute appendicitis is expected to witness higher growth over the forecast period as it is characterized by inflammation of the appendix that develops rapidly, over a period of hours or days.

Q7. In appendicitis diagnostics and treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high prevalence of appendicitis and increasing awareness of the disease among people.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the appendicitis diagnostics and treatment market by type (acute and chronic), diagnosis treatment (diagnosis and treatment), end use (hospitals, clinics, and diagnostic imaging centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Appendicitis Diagnostics and Treatment Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Appendicitis Diagnostics and Treatment Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Appendicitis Diagnostics and Treatment Market by Type
  • 3.3.1: Acute
  • 3.3.2: Chronic
• 3.4: Global Appendicitis Diagnostics and Treatment Market by Diagnosis Treatment
  • 3.4.1: Diagnosis
  • 3.4.2: Treatment
• 3.5: Global Appendicitis Diagnostics and Treatment Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Clinics
  • 3.5.3: Diagnostic Imaging Centers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Appendicitis Diagnostics and Treatment Market by Region
• 4.2: North American Appendicitis Diagnostics and Treatment Market
  • 4.2.2: North American Appendicitis Diagnostics and Treatment Market by End Use: Hospitals, Clinics, and Diagnostic Imaging Centers
• 4.3: European Appendicitis Diagnostics and Treatment Market
  • 4.3.1: European Appendicitis Diagnostics and Treatment Market by Type: Acute and Chronic
  • 4.3.2: European Appendicitis Diagnostics and Treatment Market by End Use: Hospitals, Clinics, and Diagnostic Imaging Centers
• 4.4: APAC Appendicitis Diagnostics and Treatment Market
  • 4.4.1: APAC Appendicitis Diagnostics and Treatment Market by Type: Acute and Chronic
  • 4.4.2: APAC Appendicitis Diagnostics and Treatment Market by End Use: Hospitals, Clinics, and Diagnostic Imaging Centers
• 4.5: ROW Appendicitis Diagnostics and Treatment Market
  • 4.5.1: ROW Appendicitis Diagnostics and Treatment Market by Type: Acute and Chronic
  • 4.5.2: ROW Appendicitis Diagnostics and Treatment Market by End Use: Hospitals, Clinics, and Diagnostic Imaging Centers

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Appendicitis Diagnostics and Treatment Market by Type
  • 6.1.2: Growth Opportunities for the Global Appendicitis Diagnostics and Treatment Market by Diagnosis Treatment
  • 6.1.3: Growth Opportunities for the Global Appendicitis Diagnostics and Treatment Market by End Use
  • 6.1.4: Growth Opportunities for the Global Appendicitis Diagnostics and Treatment Market by Region
• 6.2: Emerging Trends in the Global Appendicitis Diagnostics and Treatment Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Appendicitis Diagnostics and Treatment Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Appendicitis Diagnostics and Treatment Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Johnshon & Johnshon
• 7.2: Pfizer
• 7.3: Lupin
• 7.4: Siemens
• 7.5: Medtronic
• 7.6: Cook
• 7.7: Teva Pharmaceutical industries